Human Bone Marrow Cell Extracts Mitigate Radiation Injury to Salivary Gland

Area of Science:

• Regenerative Medicine
• Radiation Oncology
• Hematology

Background:

• Irradiation therapy can cause salivary gland damage, leading to hypofunction.
• Previous studies showed efficacy using mouse bone marrow extracts.

Purpose of the Study:

• To evaluate the therapeutic potential of human bone marrow cell extract (BMCE) for irradiation-induced salivary hypofunction.
• To identify the most effective cell fraction within BMCE for salivary gland repair.

Main Methods:

• Immunocompetent mice with irradiation-induced salivary injury were treated with human BMCE.
• Human bone marrow was fractionated into mononuclear cells, granulocytes, and red blood cells; their respective extracts were tested.
• Salivary flow, cell preservation, proliferation, and inflammatory responses were assessed.

Main Results:

• Human BMCE treatment increased salivary secretion by 50% without additional inflammation.
• Mononuclear cell extract (MCE) demonstrated the highest efficacy, increasing salivary flow 50-73% for 16 weeks.
• MCE preserved salivary cells, doubled proliferation rates, and induced less inflammation compared to granulocyte or red blood cell extracts.

Conclusions:

• Human BMCE, particularly the MCE fraction, is a promising therapy for irradiation-induced salivary hypofunction.
• BMCE and MCE offer advantages for clinical use, including comparable bioactivity from male/female donors and convenient storage/transport.
• The identified proangiogenic and antiangiogenic factors in MCE warrant further investigation.